"Do alternative approaches work in surgical septal myectomy?"
Praveen Kerala VarmaNeethu KrishnaRajesh JoseKirun GopalHisham AhamedPublished in: Asian cardiovascular & thoracic annals (2021)
Trans-aortic septal myectomy is the gold standard for septal reduction therapy. This technique has low peri-procedural mortality and excellent long-term survival. Moreover, it relieves the heart failure symptoms and improves the quality of life. Secondary chordal cutting along with septal myectomy has shown to improve the outcome but can potentially cause deterioration of left ventricular function. In patients with relatively thin inter-ventricular septum, abnormalities of mitral valve apparatus may be the main reason for systolic anterior motion and left ventricular outflow tract obstruction. These patients may require additional procedures on the mitral valve to shift the coaptation plane away from outflow tract. Mitral valve replacement should be performed only in patients with intrinsic mitral valve abnormalities that are not suitable for repair and its routine use along with limited septal myectomy should be discouraged. Minimal access surgery although attractive in concept requires more robust data before universal application.
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- mitral valve
- heart failure
- left atrial
- cardiac resynchronization therapy
- acute myocardial infarction
- aortic stenosis
- end stage renal disease
- chronic kidney disease
- minimally invasive
- ejection fraction
- newly diagnosed
- stem cells
- prognostic factors
- coronary artery bypass
- clinical practice
- cardiovascular events
- type diabetes
- cardiovascular disease
- blood pressure
- high speed
- machine learning
- pulmonary hypertension
- coronary artery
- mass spectrometry
- atrial fibrillation
- physical activity
- deep learning
- pulmonary artery